Trials / Recruiting
RecruitingNCT05985473
Real-time Artificial Intelligence-based Speech Enhancement Methods for Hearing Aid Improvement
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Institut Pasteur · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Individuals with Auditory Neuropathy Spectrum Disorders (ANSD) represent 1-10% of adults with hearing loss. These individuals have little or no benefit from current hearing aids because ANSD is a continuum of hearing impairments due to synaptic or neural dysfunction in the peripheral and central parts of the auditory pathways, which impairs temporal information processing without necessarily affecting auditory sensitivity. There is a need to find ad-hoc denoising methods, based on the expert knowledge of audiologists, to improve the noise comprehension performance of these patients. Implemented denoising methods, based on artificial intelligence, will also greatly benefit more standard hearing loss cases.
Detailed description
Longitudinal study consisting of multiple visits with multiple examinations over a total duration of approximately 3 years per ANSD participant and 1 year per normal hearing participant. * normal hearing participant : year 1 : Inclusion visit, Phenotyping visit (Audiological tests), Follow-up Visit 1 (Noise Comprehension Tests) * ANSD participant : year 1 : Inclusion visit, Phenotyping visit (Audiological tests), Follow-up Visit 1 (Noise Comprehension Tests) year 2 : Follow-up Visit 2 (Noise Comprehension Tests) year 3 : Follow-up Visit 3 (Noise Comprehension Tests)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | audiological measurements | audiological measurements |
| OTHER | Objective and subjective audiological measurements | Objective and subjective audiological measurements |
| OTHER | Evaluation of the denoising methods REFINED | Evaluation of the denoising methods REFINED |
Timeline
- Start date
- 2024-03-06
- Primary completion
- 2026-09-15
- Completion
- 2026-09-15
- First posted
- 2023-08-14
- Last updated
- 2024-03-15
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05985473. Inclusion in this directory is not an endorsement.